Pharma
Avarice Is Truly So Addictive
Gilead’s Lenacapavir Price Cut: A Monopoly Tactic? Gilead Sciences’ recent announcement of reduced prices for lenacapavir, its innovative HIV prevention
Continue ReadingJune 9, 2026
Gilead’s Lenacapavir Price Cut: A Monopoly Tactic? Gilead Sciences’ recent announcement of reduced prices for lenacapavir, its innovative HIV prevention
Continue ReadingEast African Nations Unite to Strengthen Medicine Regulation In a collaborative effort to bolster public health, key East African nations
Continue Reading